Marcel Moulaison

Chief Tech/Sci/R&D Officer presso IRONWOOD PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profilo

Marcel Moulaison is currently working as the Vice President-Technical Operations at Ironwood Pharmaceuticals, Inc. He previously worked as the Executive Director-Quality Operations at Sumitomo Pharma America, Inc. Mr. Moulaison completed his undergraduate degree at Dalhousie University.

Posizioni attive di Marcel Moulaison

Società	Posizione	Inizio
IRONWOOD PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01/02/2019

Tutte le posizioni attive di Marcel Moulaison

Precedenti posizioni note di Marcel Moulaison

Società	Posizione	Fine
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	Corporate Officer/Principal	01/01/2014

Vedi nel dettaglio l'esperienza di Marcel Moulaison

Formazione di Marcel Moulaison

Dalhousie University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Marcel Moulaison

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
IRONWOOD PHARMACEUTICALS, INC.	Health Technology

Aziende private	1
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	Health Technology